Hong Chow Leaves Roche China for Big New Role at Merck
In a big career move on a personal level and a sign of China’s continuing significance to global pharma, Hong Chow has left her role as General…
Tagged with Roche
Roche Hoping to Spearhead ‘Created in China’ Push with New…
In May 2021 Swiss giant Roche launched the ‘Roche Accelerator’ in Shanghai, a USD 31.1 million investment aiming to foster and capitalise on…
What Switzerland Means to Novartis & Roche
The Novartis and Roche names are synonymous with Swiss pharmaceutical innovation. But for these two Basel-based global behemoths, what value does…
India Pharma News: Global Implications of COVID Crisis; April…
The latest from Indian pharma, including the year-to-year 51.5 percent growth of the pharma market in April, Lilly’s partnership with three generics…
APAC: Diagnostics in the Post-COVID Era
COVID-19 has pushed diagnostics to the forefront of healthcare conversations across the world. Here, three leading lights from the Asia-Pacific…
The Challenges of Regulatory Convergence in APAC Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific has long been a challenging issue, predominantly due to the extreme…
Thomas F. Schmidt – Managing Director, Roche Pharma…
Thomas F. Schmidt, country manager of Roche Pharma in its home market of Switzerland discusses adjusting to his first role in general management, the…
Medtech’s Post-COVID Paradigm in APAC
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine percent, certainly its most dynamic.…
Lance Little – Managing Director (Asia Pacific), Roche…
Lance Little, managing director for Roche Diagnostics in Asia Pacific and board member of the Asia Pacific Medical Technology Association (APACMed),…
Daniel Malarek – General Manager, Roche Diagnostics Norway
Roche Diagnostics Norway’s Daniel Malarek discusses the resurgence of diagnostics in the wake of the COVID-19 pandemic, the Norwegian approval…
How Chugai Became Japan’s Top Pharma Company
In 2020, Chugai Pharmaceutical Co. became Japan’s biggest drug company, driven by strong performance in recent years both from the company’s own…
Global Pharma Execs Hail ‘Unprecedented’ Speed &…
During the fourth International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) COVID-19 media briefing, one thematic dominated:…
